z-logo
Premium
In Vitro inhibitory effects of non‐steroidal antiinflammatory drugs on UDP‐glucuronosyltransferase 1A1‐catalysed estradiol 3 β ‐glucuronidation in human liver microsomes
Author(s) -
Mano Yuji,
Usui Takashi,
Kamimura Hidetaka
Publication year - 2005
Publication title -
biopharmaceutics and drug disposition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.419
H-Index - 58
eISSN - 1099-081X
pISSN - 0142-2782
DOI - 10.1002/bdd.430
Subject(s) - glucuronidation , diflunisal , niflumic acid , naproxen , chemistry , ketoprofen , diclofenac , pharmacology , microsome , ic50 , acetaminophen , in vitro , biochemistry , chromatography , medicine , alternative medicine , pathology
The inhibitory potencies of non‐steroidal antiinflammatory drugs (NSAID) on UDP‐glucuronosyltransferase (UGT) 1A1‐catalysed estradiol 3 β ‐glucuronidation (E3G) were investigated in human liver microsomes (HLM). Inhibitory effects of the following seven NSAID were investigated: acetaminophen, diclofenac, diflunisal, indomethacin, ketoprofen, naproxen and niflumic acid. Niflumic acid had the most potent inhibitory effect on E3G with an IC 50 value of 22.2 µ M in HLM. The IC 50 values of diclofenac, diflunisal, indomethacin for E3G were 60.9, 37.8 and 51.5 µ M , respectively, while acetaminophen, ketoprofen and naproxen showed less potent inhibition. Diclofenac inhibited E3G non‐competitively with a K i value of 112 µ M in HLM. The IC 50 value of diclofenac for 4‐methylumbelliferone glucuronidation in recombinant human UGT1A1 was 57.5 µ M , similar to that obtained for E3G using HLM. In conclusion, niflumic acid had the most potent inhibitory effects on UGT1A1‐catalysed E3G in HLM among seven NSAID investigated. Copyright © 2004 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom